Implantation life is dependent on the depth and location of injection, and averages 6-12 months.

Revanesse® Ultra™ with Lidocaine is a cross-linked hyaluronic acid gel indicated for the treatment of facial rhytides and lipoatrophy by injection into the skin.

Revanesse® Ultra™ with Lidocaine is a medium viscosity, versatile hyaluronic acid gel used to correct deeper wrinkles and folds, providing volume to help restore and contour facial features. It is a colorless, odorless, transparent, and aqueous gel of synthetic origin.

• Revanesse® Ultra™ with Lidocaine should only be injected by or under the direct supervision of qualified physicians trained on the proper injection technique for filling facial wrinkles.
• Before treatment, inform patients of the device’s indications, contraindications, and potential side effects.
• Thoroughly disinfect the treatment area and inject under sterile conditions.
• Inject the product slowly and with the least amount of pressure necessary.
• Revanesse® Ultra™ with Lidocaine and needles are for single use only. Do not re-use to avoid infection or transmission of bloodborne diseases.
• Keep the product at room temperature for 30 minutes before injection.
• If skin turns white (blanching), stop injection immediately and massage the area until the skin returns to normal color.
• Before injecting, press the syringe plunger until a small drop is visible at the needle tip.

Contraindications:

• Contains lidocaine and is contraindicated for patients with a history of allergies to such material.
• Do not inject into eye contours, blood vessels, or pregnant or lactating women.
• Avoid use in patients with hypertrophic scarring, allergies to bacterial proteins, or autoimmune disorders.
• Never use in conjunction with laser, intense pulsed light, chemical peeling, or dermabrasion treatments.
• Avoid in patients under 18, with acne or inflammatory skin diseases, with unattainable expectations, or undergoing immunotherapy.
• Avoid in patients with coagulation defects or sensitivity to hyaluronic acid.

After-care:

• Avoid touching the treated area for 12 hours and prolonged exposure to sunlight, UV, extreme cold, and heat.
• Avoid intense heat or cold until initial swelling and redness resolve.
• Risk of cold sore eruption exists if previously suffered; medications like aspirin or NSAIDs may increase bruising and bleeding.
• Limit lidocaine use to 20 mL per 60 kg body mass per annum; avoid treatment during bacterial/viral infections or active fever.